EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Blood and guts: how the intestinal microbiome shapes hematopoiesis and treatment of hematologic disease

Josaura Fernandez Sanchez, Arushana A Maknojia, Katherine Y King iD

Blood · 25.04.2024 · 143 (17) · 1689-1701

DOI: 10.1182/blood.2023021174 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Blood, erschienen am 25.04.2024. Verfasst von Josaura Fernandez Sanchez und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Hematopoiesis, Hematologic Diseases. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over the past 10 years, there has been a marked increase in recognition of the interplay between the intestinal microbiome and the hematopoietic system. Despite their apparent distance in the body, a large literature now supports the relevance of the normal intestinal microbiota to steady-state blood production, affecting both hematopoietic stem and progenitor cells as well as differentiated immune cells. Microbial metabolites enter the circulation where they can trigger cytokine signaling that influences hematopoiesis. Furthermore, the state of the microbiome is now recognized to affect outcomes from hematopoietic stem cell transplant, immunotherapy, and cellular therapies for hematologic malignancies. Here we review the mechanisms by which microbiotas influence hematopoiesis in development and adulthood as well as the avenues by which microbiotas are thought to impact stem cell transplant engraftment, graft-versus-host disease, and efficacy of cell and immunotherapies. We highlight areas of future research that may lead to reduced adverse effects of antibiotic use and improved outcomes for patients with hematologic conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeHematopoiesisHematologic DiseasesHumansAnimalsHematopoietic Stem Cell TransplantationGraft vs Host Disease

Autor:innen und Institutionen

  • Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX.
  • Program in Immunology and Microbiology, Graduate School of Biomedical Sciences, Baylor College of Medicine, Houston, TX.
  • Division of Infectious Diseases, Department of Pediatrics, and Center for Cell and Gene Therapy, Baylor College of Medicine and Texas Children's Hospital, Houston, TX.

ORCID-Profile: Katherine Y King

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NCI NIH HHS

Zitieren

APA

Fernandez Sanchez, J., Maknojia, A. A., & King, K. Y. (2024). Blood and guts: how the intestinal microbiome shapes hematopoiesis and treatment of hematologic disease. Blood, 143(17), 1689-1701. https://doi.org/10.1182/blood.2023021174

Vancouver

Fernandez Sanchez J, Maknojia AA, King KY. Blood and guts: how the intestinal microbiome shapes hematopoiesis and treatment of hematologic disease. Blood. 2024;143(17):1689-1701. doi:10.1182/blood.2023021174

BibTeX
@article{FernandezSanchez2024,
  author = {Fernandez Sanchez, Josaura and Maknojia, Arushana A and King, Katherine Y},
  title = {Blood and guts: how the intestinal microbiome shapes hematopoiesis and treatment of hematologic disease},
  journal = {Blood},
  year = {2024},
  volume = {143},
  number = {17},
  pages = {1689--1701},
  doi = {10.1182/blood.2023021174}
}
Kostenlos starten →